One backend. Eight specialised tools. Watch every SFDA registration, pipeline entry, recall, tender, and e-pharmacy shelf change across Saudi Arabia — enriched by AI, delivered within the hour.
Built for BD, market-access & regulatory teams — pharma, biotech, generics, medical devices & consumer health.
Each tool is sold separately. Each shares the same RaqibHealth ingestion backend. Each costs less than the analyst it replaces.
Not a slow consultancy report. Not a generic SaaS dashboard. A precise tool for a specific market.
One backend ingests the whole SFDA universe — drug, device, food and cosmetic registers — and joins it with global signals. Each module is a focused frontend on the same source of truth.
AI reads every drug record — originator, therapy area, strategic flag. Then ask it anything: Ask RaqibHealth answers in plain English, grounded in the live registry.
Drugs approved abroad but not yet in KSA, Saudi trials, and US patent cliffs that open generic windows — ranked, with entry windows from the measured FDA → SFDA lag.
The full SFDA registers — sliceable by dosage form and consumer-health segment — cross-matched with US FDA, EMA and Saudi clinical-trial data.
Arabic source records read and surfaced in English, by a team fluent in the Saudi market. Arabic UI on the roadmap.
Annual, per-organisation licensing — PO-friendly, multi-seat and ready for security review.
Regulatory data is scattered across formats, languages, and systems that keep no memory of what changed. RaqibHealth turns it into a living decision layer — current, connected, and tracked over time, ranked by what matters to your brand.
Static, siloed, raw tables no one can act on.
Dynamic, ranked, live decisions leaders can make.
No magic. Just boring, well-engineered infrastructure that runs on a clock.
25+ sources, each monitored at the right cadence — critical signals like new approvals and recalls within the hour. The infrastructure is boring on purpose.
Every record is enriched into decision-ready intelligence — originator brand, therapy area, a market-impact read and a strategic flag — with a human-review backstop on lower-confidence calls.
Each subscriber’s watchlist is checked against new records. Matches trigger email alerts within the hour. The Monday digest summarises the week.
Annual, per-organisation, with seats. Catching one generic wave or launch window early can defend millions in brand revenue — RaqibHealth is a fraction of that, and a fraction of the global CI suites, because it’s built only for KSA.
Founding cohort — the first 10 organisations get 40% off year one, locked for 12 months · multi-year & multi-affiliate discounts · single modules available à la carte. info@raqibhealth.com
Start with the free Pulse digest — every SFDA recall and the week’s top launches. Founding pricing for the first teams aboard. Your competitor isn’t watching this yet — but they will.
No credit card for Pulse · talk to us at info@raqibhealth.com for a team plan.